Mometasone furoate
Nasopronal nasal spray contains mometasone furoate, which belongs to a group of medicines called corticosteroids.
Mometasone furoate administered intranasally relieves the symptoms of inflammation (swelling and irritation of the nasal mucosa), sneezing, itching, and a feeling of a blocked nose, and reduces the amount of nasal discharge.
Hay fever and perennial allergic rhinitis
Nasopronal is used to treat the symptoms of hay fever (also known as seasonal allergic rhinitis) and perennial allergic rhinitis in adults and children aged 6 years and older.
Hay fever, which occurs at certain times of the year, is an allergic reaction caused by inhaling pollen from trees, grasses, weeds, and mold spores.
Perennial allergic rhinitis occurs throughout the year, and the symptoms can be caused by sensitivity to various factors, including house dust mites, animal dander (or shed skin), feathers, and some foods. Nasopronal reduces the swelling and irritation of the nasal mucosa, thereby relieving sneezing, itching, a feeling of a blocked nose, or nasal discharge caused by hay fever or perennial allergic rhinitis.
Nasal polyps
Nasopronal is used to treat nasal polyps in adults aged 18 years and older.
Nasal polyps are small growths on the nasal mucosa, usually occurring in both nostrils.
Nasopronal reduces the inflammation in the nose, causing a gradual reduction in the size of the nasal polyps, thereby reducing the feeling of a blocked nose, which can make breathing difficult.
Before starting to use Nasopronal, you should discuss this with your doctor or pharmacist:
While using Nasopronal, you should discuss this with your doctor
If you experience blurred vision or other vision disturbances, you should contact your doctor.
If corticosteroids in the form of a nasal spray are taken in high doses for a long time, they may cause side effects due to the absorption of the medicine into the body.
If you experience itching or irritation of the eyes, your doctor may recommend other treatment with Nasopronal.
If corticosteroids in the form of a nasal spray are taken in high doses for a long time, they may cause certain side effects, such as slowing down the growth rate in children.
It is recommended that the growth of children receiving long-term treatment with nasal corticosteroids be regularly monitored, and if any changes are observed, the doctor should be informed.
You should tell your doctor or pharmacist about all medicines you are taking, or have recently taken, and about any medicines you plan to take, including those available without a prescription.
If you are taking other corticosteroids orally or by injection to treat allergies, your doctor may recommend that you stop taking them when you start using Nasopronal. In some patients, after stopping oral or injected corticosteroids, side effects such as joint or muscle pain, weakness, and depression may occur. Other allergic symptoms, such as itching, tearing of the eyes, or red and itchy skin patches, may also appear. You should contact your doctor if you experience any of these symptoms.
Certain medicines may enhance the effect of Nasopronal, and your doctor may want to monitor your condition closely while you are taking such medicines (including certain medicines for HIV: ritonavir, cobicistat).
There are no data or only limited data available on the use of Nasopronal in pregnant women.
It is not known whether mometasone furoate passes into breast milk.
If you are pregnant or breastfeeding, think you may be pregnant, or plan to have a child, you should consult your doctor or pharmacist before using this medicine.
There are no data available on the effect of Nasopronal on the ability to drive or use machines.
The medicine contains 0.02 mg of benzalkonium chloride per dose.
Benzalkonium chloride may cause irritation or swelling inside the nose, especially if used for a long time.
Nasopronal should always be used as directed by your doctor. If you are unsure, you should consult your doctor or pharmacist.
The nasal spray should not be used more frequently, for a longer period, or in higher doses than recommended by your doctor.
Usually, two doses of the nasal spray are used in each nostril once a day.
In some patients, relief of symptoms occurs within 12 hours of administration of the first dose of Nasopronal, but the full benefits of treatment may not be observed until after 2 days of treatment. It is very important that you use the nasal spray regularly to get the full benefits of treatment.
If you have severe symptoms of hay fever, your doctor may recommend starting to use Nasopronal a few days before the expected start of the pollen season. This will help prevent the symptoms of hay fever from occurring.
After improvement, your doctor may recommend reducing the dose of the medicine.
Nasopronal nasal spray contains a protective cap that protects the tip of the actuator and prevents it from becoming contaminated. Remember to remove it before using the spray and replace it after use.
Before using the spray for the first time, you should check that it works by pressing the pump 10 times until a fine mist is produced:
Figure 1
Figure 2
Figure 3
After using the nasal spray, you should carefully wipe the tip of the actuator with a clean tissue or cloth and replace the protective cap.
Cleaning
If you accidentally use a higher dose of the medicine than recommended, you should contact your doctor.
If corticosteroids are used for a long period or in high doses, they may have an adverse effect on your hormones. In children, they may affect growth and development.
If you forget to use the nasal spray at the right time, you should use it as soon as you remember, and then continue with your regular treatment schedule.
Do not use a double dose to make up for a forgotten dose.
In some patients, relief of symptoms occurs within 12 hours of administration of the first dose of Nasopronal, but the full benefits of treatment may not be observed until after 2 days of treatment. It is very important that you use the nasal spray regularly. You should not stop treatment, even if you feel better, unless your doctor recommends it.
If you have any further questions about the use of this medicine, you should ask your doctor or pharmacist.
Like all medicines, Nasopronal can cause side effects, although not everybody gets them.
After using this medicine, immediate allergic reactions (hypersensitivity) may occur. These reactions can be severe. You should stop using Nasopronal and seek medical help immediately if you experience symptoms such as:
If corticosteroids in the form of a nasal spray are taken in high doses for a long time, side effects may occur due to the absorption of the medicine into the body.
Other side effects
Most people using nasal sprays do not experience any side effects. However, in some people, after using Nasopronal or another corticosteroid nasal spray, the following side effects have occurred:
Common side effects (may affect up to 1 in 10 people):
Frequency not known (frequency cannot be estimated from the available data):
If you experience any side effects, including those not listed in this leaflet, you should tell your doctor or pharmacist. You can also report side effects directly to the Department of Drug Safety Monitoring, Office for Registration of Medicinal Products, Medical Devices, and Biocidal Products, Al. Jerozolimskie 181C, 02-222 Warsaw, tel.: +48 22 49 21 301, fax: +48 22 49 21 309, e-mail: ndl@urpl.gov.pl
Side effects can also be reported to the marketing authorization holder.
By reporting side effects, you can help provide more information on the safety of this medicine.
Do not freeze.
The shelf life after first opening is 2 months.
Keep the medicine out of the sight and reach of children.
Do not use this medicine after the expiry date stated on the bottle and carton after EXP.
The expiry date refers to the last day of the month.
Medicines should not be disposed of via wastewater or household waste. You should ask your pharmacist how to dispose of medicines that are no longer required. This will help protect the environment.
Nasopronal is a nasal spray, in the form of a white or almost white, opaque suspension, packaged in an HDPE bottle with a dosing pump and a polypropylene applicator with a protective cap, in a cardboard box.
Pack sizes:
Vitama S.A.
Bonifraterska 17 Street
00-203 Warsaw
MIPHARM S.p.A.
Via Quaranta 12,
20141 Milan
Italy
Need help understanding this medicine or your symptoms? Online doctors can answer your questions and offer guidance.